Dr. Patel is currently the founder and managing director of Patel Family Investments (2014), an industry luminary and an active investor in over 20 biotech and technology companies from around the world. As part of this investment activity he co-founded and was the managing director of vSpring Capital ($400 million under management) from 2000-2014.

Prior to his work as a full-time bio-tech investor he co-founded and led several biotech companies, many of which were sold or secured successful IPOs.   They include:

• TheraTech, Inc., a biotech company focused on the development and commercialization of innovative therapies (co-founder, chairman of the board & CEO) which was sold to Watson Pharmaceuticals (now Actavis) for $350 million (1985-1999).
• Ashni Naturaceuticals, Inc., a company that specializes in the research, development and marketing of clinically tested naturaceutical products (Founder, Chairman & CEO) (1999 to 2004).
• Salus Therapeutics, Inc., a biotechnology company focused on the research and development of nucleic acid-based therapeutics, including antisense and gene therapy drugs (co-founder and chairman of the board) (1999).

Dr. Patel also served on the board of Mediconnect Global, a worldwide leader in medical record retrieval, digitization, and one of the largest cloud based health information exchanges. In March 2012 Mediconnect was acquired by Verisk Analytics (VRSK) for over $377 million. He currently holds 15 US Patents and Foreign Counterparts.